Well, well, well, it looks like Moderna’s CEO Stéphane Bancel got a good old-fashioned roasting from Senator Rand Paul in the Senate yesterday. Bancel had to answer some tough questions about his company’s Covid-19 vaccine, which has made Moderna nearly $20 billion in 2022 alone and is projected to bring in another $5 billion this year. (Moderna also plans to quadruple the price of a single dose in the U.S. from around $26 to a whopping $130. That’s quite the cash grab!)
The real heat came when Senator Paul confronted Bancel about the increased risk of myocarditis in young men who take the vaccine.
Bancel clearly tried to dance around the issue, claiming that the data from the CDC shows less myocarditis in people who get the vaccine compared to those who get the infection. But Senator Paul wasn’t having it and slammed Bancel with six peer-reviewed papers that say the complete opposite of what he claimed.
And to add insult to injury, Senator Paul revealed that he spoke with Moderna’s president just last week, who readily acknowledged in private that there is, in fact, an increased risk of myocarditis. The fact that Bancel couldn’t admit this in public is downright disturbing.
It’s time for these vaccine companies to be held accountable for the risks associated with their products, and it’s clear that Moderna has some explaining to do. Let’s hope our elected officials continue to grill these CEOs until they come clean about the dangers of their vaccines.